Viewing Study NCT02953561


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2026-05-18 @ 3:34 PM
Study NCT ID: NCT02953561
Status: TERMINATED
Last Update Posted: 2020-10-22
First Post: 2016-11-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
Keywords: